Advertisement
Screener

PROFOUND MEDICAL CORP. (PROF) Current Liabilities

2.8 / 5 stars · 68/120 Roast Me

PROFOUND MEDICAL CORP. Current Liabilities

PROFOUND MEDICAL CORP. (PROF) had Current Liabilities of $6.37 million as of 2023-12-31, per its 40-F filed 2024-03-07.

Discontinued › Notes

ifrs-full:CurrentLiabilities · last filed 2024-03-07

  • 2019-12-31: Current Liabilities 10.68M CAD; Current Liabilities as first filed 10.68M CAD.
  • 2019-01-01: Current Liabilities 7.88M CAD.
  • 2018-12-31: Current Liabilities 7.88M CAD.

CAD

Period endCurrent LiabilitiesCurrent Liabilities as first filed
2019-12-3110.68M CAD
40-F · filed 2021-03-02
10.68M CAD
40-F · filed 2020-03-03
2019-01-017.88M CAD
40-F · filed 2021-03-02
2018-12-317.88M CAD
40-F · filed 2020-03-03

USD

Period endCurrent Liabilities
2023-12-31$6.37M
40-F · filed 2024-03-07
2022-12-31$4.18M
40-F · filed 2024-03-07
2021-12-31$4.16M
40-F · filed 2023-03-07
2020-12-31$4.81M
40-F · filed 2022-03-03
2019-12-31$8.22M
40-F · filed 2021-03-02
2019-01-01$5.78M
40-F · filed 2021-03-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neuronetics, Inc. (STIM)United States$0.216B-3.25
PRO DEX INC (PDEX)United States$0.234B13.64
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Lucid Diagnostics Inc. (LUCD)United States$0.170B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
KORU Medical Systems, Inc. (KRMD)United States$0.151B-106.78
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92